Amanda Mathew, Ph.D. | American Lung Association

This website uses cookies. By continuing you are agreeing to our privacy policy.

Amanda Mathew, Ph.D.

Northwestern University
Smoking Cessation Program Specifically Designed for COPD Patients

Chronic obstructive pulmonary disease (COPD) is caused primarily by smoking, and smoking cessation is the first-line treatment for slowing disease progression. Smokers with COPD report high rates of co-occurring conditions—nicotine dependence, depression, and anxiety—which are barriers to quitting. There is limited understanding of the psychological risk factors that commonly drive these conditions and how they can be addressed through targeted behavioral treatment. We will develop a novel smoking cessation intervention among COPD patients and use data from patients and providers to guide treatment delivery. Findings will guide a randomized, controlled trial to test an intervention with important implications for improving behavioral health and reducing morbidity and mortality among COPD patients.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.


LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.